Nature Retracts Cancer Study Linking Treatment Timing to Survival

— Editors "no longer have confidence in the integrity of the results"

June 24, 2026

• 2 min read

After a 4-month investigation, Nature Medicine retracted a study that showed that the time of day in which immunochemotherapy was given for non-small cell lung cancer (NSCLC) had an effect on survival outcomes.

In the phase III trial known as LungTIME-C01, which was published in February, Chinese researchers reported that NSCLC patients who received immunochemotherapy in the morning or early afternoon had better survival outcomes compared with those who received treatment later in the day.